Identify and Validate Innovative Peptides for the Treatment of Obesity
The Pharma Data
MARCH 2, 2021
The companies share the goal of providing new obesity therapies with increased tolerability that support greater weight loss than current therapy options. We are committed to becoming a leader in the obesity space and to providing new therapy options to help people with high unmet medical needs.”. About Boehringer Ingelheim.
Let's personalize your content